Cargando…

Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most prevalent tumors worldwide and the leading contributor to cancer-related deaths. The progression and metastasis of HCC are closely associated with altered mitochondrial metabolism, including mitochondrial stress response. Mitokines, soluble proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiang, Luo, Lan-Zhu, Liang, Dao-Miao, Guo, Chao, Huang, Zhi-Hong, Jian, Xiao-Hong, Wen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450380/ https://www.ncbi.nlm.nih.gov/pubmed/37637689 http://dx.doi.org/10.12998/wjcc.v11.i23.5416

Ejemplares similares

Mitochondrial stress and mitokines in aging
por: Burtscher, Johannes, et al.
Publicado: (2023)

Regulation of diurnal energy balance by mitokines
por: Klaus, Susanne, et al.
Publicado: (2021)

Mitochondria, immunosenescence and inflammaging: a role for mitokines?
por: Conte, Maria, et al.
Publicado: (2020)

Metabolic remodeling induced by mitokines in heart failure
por: Duan, Jiahao, et al.
Publicado: (2019)

Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity
por: Ahmed, Darakhshan Sohail, et al.
Publicado: (2022)

Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases
por: Yi, Hyon-Seung
Publicado: (2019)

Both objective and paradoxical insomnia elicit a stress response involving mitokine production
por: Martucci, Morena, et al.
Publicado: (2020)

Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study
por: Amado, Carlos A., et al.
Publicado: (2022)

Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
por: Li, Jiarui, et al.
Publicado: (2023)

Recent progress in the emerging role of exosome in hepatocellular carcinoma
por: Abudoureyimu, Mubalake, et al.
Publicado: (2018)

Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis
por: Liao, Ziyue, et al.
Publicado: (2023)

Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects
por: Xiao, Zhangang, et al.
Publicado: (2018)

Diagnostic and Therapeutic Approaches to Hepatocellular Carcinoma: Understanding the Barcelona Clínic Liver Cancer Protocol
por: Soldera, Jonathan, et al.
Publicado: (2016)

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

Progress in the research of cuproptosis and possible targets for cancer therapy
por: Wang, Jiang, et al.
Publicado: (2023)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging
por: Conte, Maria, et al.
Publicado: (2020)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015)

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target
por: Hung, Chao-Hung, et al.
Publicado: (2014)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Circular RNAs in hepatocellular carcinoma: Recent advances
por: Niu, Zhao-Shan, et al.
Publicado: (2022)

Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review)
por: Luo, Wenyu, et al.
Publicado: (2022)

Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
por: Liang, Chen, et al.
Publicado: (2022)

Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
por: Liu, Ruiqi, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Editorial: Recent advances in the understanding of hepatocellular carcinogenesis
por: Banini, Bubu A., et al.
Publicado: (2022)

Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma
por: Bouattour, Mohamed, et al.
Publicado: (2018)

Virus-Induced Risk of Hepatocellular Carcinoma: Recent Progress and Future Challenges
por: Lupberger, Joachim, et al.
Publicado: (2021)

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
por: De Matteis, Serena, et al.
Publicado: (2018)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
por: Shen, Chen, et al.
Publicado: (2023)

Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma
por: Sun, Jin‐Yu, et al.
Publicado: (2020)

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
por: Wang, Yijun, et al.
Publicado: (2021)

Recent Progress in the Understanding of the Effect of Sympathetic Nerves on Hair Follicle Growth
por: Zhang, Jiarui, et al.
Publicado: (2021)

Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
por: Tang, Rui, et al.
Publicado: (2023)

Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study
por: Chen, Yang, et al.
Publicado: (2016)

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Recent Progress in the Identification of Aptamers Against Bacterial Origins and Their Diagnostic Applications
por: Trunzo, Nevina E., et al.
Publicado: (2020)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c89tglltjao9gbdg33r5atcppo